Efficacy and toxicity of HER2-targeted antibody-drug conjugates (ADCs) in the treatment of metastatic urothelial cancer (mUC): A systematic review

Category Systematic review
JournalAnnals of Oncology
Year 2022
This article has no abstract
Epistemonikos ID: d38a88d3cf12dc3c4aaf3db969246fee7e430e66
First added on: Feb 15, 2025